VEGFC and cancer: BRG1 loss function mutation has been found in several kinds of cancers, and our demonstration of the important role of the BRG1/STAT3/VEGFC in tumor-associated lymphangiogenesis might lead to the discovery of novel therapeutic targets to treat cancer with BRG1 loss of function.